Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • About Our Firm
  • Free Case Evaluation
  • Frequently Asked Questions

Some Information About Our Monthly Law Firm Newsletter

March 8, 2021 By Law Offices of Thomas J. Lamb, P.A.

The Lamb Law Office Newsletter is a monthly communication from our law firm to help keep you up to date with some of the cases that we are working on for clients at the present time. In addition, we provide at least one information resource item per month, which you or someone you know might find helpful from time to time.

Past Newsletter Editions

For your convenience, below we have presented a summary and link for the most recent editions of the Lamb Law Office Newsletter.

May 2022 – In this newsletter, we cover the litigation surrounding Benzene, a widely-used chemical known to cause acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). We also provide information regarding medical record copying costs by state.

April 2022 – In this newsletter, we provide readers with a brief overview of our current Asbestos, Benzene, Drug Injury and Breast Implant Lawsuits. We also provide an information resource reporting on every step to simple online security.

March 2022 – In this newsletter, we cover the drug injury litigation regarding the bladder cancer drug, Padcev, and the recent skin reactions involving toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). We also provide information for ConsumerMedSafety.org, a free online health information resource.

February 2022 – In this newsletter, we cover the drug injury litigation regarding the three types of Mesothelioma in detail, providing background information for the topic. We also provide information for Medline Plus, a free online health information resource.

January 2022 – In this newsletter, we cover the recent side effect warning for Xeljanz, Rinvoq and Olumiant released by the FDA.  We also provide readers with an updated information resource addressing COVID-19 self test FAQs and updated isolation and quarantine information.

December 2021 – In this newsletter, we cover the drug injury litigation regarding the recent updates in the Philips CPAP Machines Recall. We also provide readers with an updated information resource addressing COVID-19 vaccine booster shots FAQs.

November 2021 – In this newsletter, we cover bladder cancer drug, Padcev, and the recent skin reactions involving toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). We also provide readers with an information resource addressing COVID-19 vaccine booster shots FAQs.

October 2021 – In this newsletter, we cover the recent side effect warning for Xeljanz released by the FDA. We also provide readers with an information resource addressing flu vaccine information.

September 2021 – In this newsletter, we provide research resources for drug safety and warnings information. We also provide readers with an information resource regarding FAQs surrounding children and the COVID-19 pandemic.

August 2021 – There was no newsletter sent out for the month of August in 2021.

July 2021 – In this newsletter, we cover the drug injury litigation regarding the recent Philips CPAP Machines Recall. We also provide readers with a new resource with medication safety tips for older adults.

June 2021 – In this newsletter, we cover the drug injury litigation regarding Mesothelioma / Lung Cancer / Asbestosis in detail, providing background information for the topic. We also provide readers with a new resource for Alzheimer’s and related Dementias.

May 2021 – In this newsletter, we provide readers with an information resource regarding hurricane and natural disaster preparedness. We also give readers a brief overview of our firm’s practice areas.

April 2021 – In this newsletter, we provide reader’s with information on how to check your credit report each week for free until 2022. We also provide various legal and medical resources to assist in locating useful, well-presented information. 

March 2021 – In this newsletter, we cover three litigations which we are currently handling, Injectafer, Belviq and Ocaliva. We also provide information regarding the American Cancer Society’s Cancer Resource Center.

February 2021 – In this newsletter, we cover three litigations we are currently handling including Xeljanz, Beovu, and Asbestos in Talcum Powder Products. We also provide readers with information regarding individuals’ rights under HIPPA to access their health information.

January 2021 – In this newsletter, we provide readers with a brief overview of our current Drug Injury Lawsuits. We also provide information clarifying the differences between drug interactions, side effects, and allergies. Lastly, there is information from the CDC about the COVID-19 Vaccine.

December 2020 – In this newsletter, we cover the drug injury litigation regarding the SGLT2 Inhibitors class of diabetes drugs (Inovanka, Farxiga, Jardiance, etc.). We also provide information on how to report adverse drug reactions to the FDA MedWatch Program. In addition, we point out the updated CDC Domestic Travel Guidelines.

November 2020 – In this newsletter, we cover two different litigations which we are currently handling, Injectafer and GenX. We also provide information regarding CDC Holiday Gathering Recommendations.

October 2020 – In this newsletter, we cover these three litigation areas: Asbestos – Mesothelioma; Benzene; and, Belviq. We also provide information for Medline Plus, a free online health information resource.

September 2020 – In this newsletter, we cover a few litigations we are currently handling, Breast Implant Devices, Elmiron, and Beovu. We also provide information regarding medical record copying costs by state.

 

(Last Updated: May 31, 2022)

 

Newsletter Sign-up Form

You can sign up to receive our monthly newsletter by completing this form.

Subscribe

* indicates required
 
 

Filed Under: Uncategorized Tagged With: Asbestos Mesothelioma, Belviq, benzene, Beovu, breast implants, Elmiron, genx, Injectafer, Lamb Law Office Newsletter, Law Firm Newsletter, Monthly Newsletter, Newsletter, sglt2 inhibitors, Xeljanz

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • Philips Breathing Devices Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2022 · Law Offices of Thomas J. Lamb, P.A.